These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27178901)
1. Complications from Nasolabial Fold Injection of Calcium Hydroxylapatite for Facial Soft-Tissue Augmentation: A Systematic Review and Meta-Analysis. Shi XH; Zhou X; Zhang YM; Lei ZY; Liu T; Fan DL Aesthet Surg J; 2016 Jun; 36(6):712-7. PubMed ID: 27178901 [TBL] [Abstract][Full Text] [Related]
2. Safety and effectiveness of injection of calcium hydroxylapatite via blunt cannula compared to injection by needle for correction of nasolabial folds. Beer KR J Cosmet Dermatol; 2014 Dec; 13(4):288-96. PubMed ID: 25399621 [TBL] [Abstract][Full Text] [Related]
3. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds. Marmur E; Green L; Busso M Dermatol Surg; 2010 Mar; 36(3):309-15. PubMed ID: 20100272 [TBL] [Abstract][Full Text] [Related]
4. Calcium Hydroxylapatite With Integral Lidocaine Provides Improved Pain Control for the Correction of Nasolabial Folds. Schachter D; Bertucci V; Solish N J Drugs Dermatol; 2016 Aug; 15(8):1005-10. PubMed ID: 27538003 [TBL] [Abstract][Full Text] [Related]
5. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Tzikas TL Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188 [TBL] [Abstract][Full Text] [Related]
6. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds. Carruthers A; Liebeskind M; Carruthers J; Forster BB Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186 [TBL] [Abstract][Full Text] [Related]
7. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2). Emer J; Sundaram H J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235 [TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Moers-Carpi M; Vogt S; Santos BM; Planas J; Vallve SR; Howell DJ Dermatol Surg; 2007 Dec; 33 Suppl 2():S144-51. PubMed ID: 18086052 [TBL] [Abstract][Full Text] [Related]
10. Open-Label, Post-Marketing Study to Evaluate the Performance and Safety of Calcium Hydroxylapatite With Integral Lidocaine to Correct Facial Volume Loss. Muti GF J Drugs Dermatol; 2019 Jan; 18(1):86-91. PubMed ID: 30681803 [TBL] [Abstract][Full Text] [Related]
11. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Sadick NS; Katz BE; Roy D Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049 [TBL] [Abstract][Full Text] [Related]
12. A randomized, split-face, histomorphologic study comparing a volumetric calcium hydroxylapatite and a hyaluronic acid-based dermal filler. Yutskovskaya Y; Kogan E; Leshunov E J Drugs Dermatol; 2014 Sep; 13(9):1047-52. PubMed ID: 25226004 [TBL] [Abstract][Full Text] [Related]
13. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen. Lapatina NG; Pavlenko T J Drugs Dermatol; 2017 Sep; 16(9):900-906. PubMed ID: 28915285 [TBL] [Abstract][Full Text] [Related]
14. Calcium hydroxylapatite: A review on safety and complications. Kadouch JA J Cosmet Dermatol; 2017 Jun; 16(2):152-161. PubMed ID: 28247924 [TBL] [Abstract][Full Text] [Related]
15. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions. Alam M; Yoo SS J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371 [TBL] [Abstract][Full Text] [Related]
16. An investigation of changes in physical properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine. Busso M; Voigts R Dermatol Surg; 2008 Jun; 34 Suppl 1():S16-23; discussion S24. PubMed ID: 18547176 [TBL] [Abstract][Full Text] [Related]
17. A retrospective review of calcium hydroxylapatite for correction of volume loss in the infraorbital region. Hevia O Dermatol Surg; 2009 Oct; 35(10):1487-94. PubMed ID: 19614938 [TBL] [Abstract][Full Text] [Related]
18. Calcium Hydroxyapatite Filler With Integral Lidocaine CaHA (+) for Soft Tissue Augmentation: Results from an Open-Label Multicenter Clinical Study. Pavicic T; Sattler G; Fischer T; Dirschka T; Kerscher M; Gauglitz G; Dersch H; Kravtsov M; Heide I; Prager W J Drugs Dermatol; 2022 May; 21(5):481-487. PubMed ID: 35533030 [TBL] [Abstract][Full Text] [Related]
19. Pilot Study Examining the Safety and Efficacy of Calcium Hydroxylapatite Filler With Integral Lidocaine Over a 12-Month Period to Correct Temporal Fossa Volume Loss. Juhász MLW; Levin MK; Marmur ES Dermatol Surg; 2018 Jan; 44(1):93-100. PubMed ID: 28858938 [TBL] [Abstract][Full Text] [Related]
20. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Smith S; Busso M; McClaren M; Bass LS Dermatol Surg; 2007 Dec; 33 Suppl 2():S112-21; discussion S121. PubMed ID: 18086048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]